Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage

Kwok-Tung Lu, Chang Yen Wu, Nai Chi Cheng, Yu Yuan Peter Wo, Jen Tsung Yang, Hao Han Yen, Yi Ling Yang

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32% compared with 78.38 ± 0.62% of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28%) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.

Original languageEnglish
Pages (from-to)99-105
Number of pages7
JournalEuropean Journal of Pharmacology
Volume548
Issue number1-3
DOIs
Publication statusPublished - 2006 Oct 24

Fingerprint

Choroid Plexus
Brain Edema
Member 2 Solute Carrier Family 12
Contusions
Bumetanide
Water
Traumatic Brain Injury
Animal Models
Western Blotting
RNA
Staining and Labeling
Polymerase Chain Reaction
Messenger RNA
Membranes

Keywords

  • Brain edema
  • Bumetanide
  • Na-K-2Cl cotransporter
  • Traumatic brain injury

ASJC Scopus subject areas

  • Pharmacology

Cite this

Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. / Lu, Kwok-Tung; Wu, Chang Yen; Cheng, Nai Chi; Wo, Yu Yuan Peter; Yang, Jen Tsung; Yen, Hao Han; Yang, Yi Ling.

In: European Journal of Pharmacology, Vol. 548, No. 1-3, 24.10.2006, p. 99-105.

Research output: Contribution to journalArticle

Lu, Kwok-Tung ; Wu, Chang Yen ; Cheng, Nai Chi ; Wo, Yu Yuan Peter ; Yang, Jen Tsung ; Yen, Hao Han ; Yang, Yi Ling. / Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. In: European Journal of Pharmacology. 2006 ; Vol. 548, No. 1-3. pp. 99-105.
@article{6e62b820e72046528a919c58f2ae4df2,
title = "Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage",
abstract = "The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32{\%} compared with 78.38 ± 0.62{\%} of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28{\%}) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.",
keywords = "Brain edema, Bumetanide, Na-K-2Cl cotransporter, Traumatic brain injury",
author = "Kwok-Tung Lu and Wu, {Chang Yen} and Cheng, {Nai Chi} and Wo, {Yu Yuan Peter} and Yang, {Jen Tsung} and Yen, {Hao Han} and Yang, {Yi Ling}",
year = "2006",
month = "10",
day = "24",
doi = "10.1016/j.ejphar.2006.07.048",
language = "English",
volume = "548",
pages = "99--105",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage

AU - Lu, Kwok-Tung

AU - Wu, Chang Yen

AU - Cheng, Nai Chi

AU - Wo, Yu Yuan Peter

AU - Yang, Jen Tsung

AU - Yen, Hao Han

AU - Yang, Yi Ling

PY - 2006/10/24

Y1 - 2006/10/24

N2 - The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32% compared with 78.38 ± 0.62% of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28%) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.

AB - The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32% compared with 78.38 ± 0.62% of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28%) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.

KW - Brain edema

KW - Bumetanide

KW - Na-K-2Cl cotransporter

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=33748714959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748714959&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.07.048

DO - 10.1016/j.ejphar.2006.07.048

M3 - Article

C2 - 16962576

AN - SCOPUS:33748714959

VL - 548

SP - 99

EP - 105

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -